Clinical characteristics of KRAS mutation subtypes in non-small cell lung cancer population in Xinjiang, China, and their impact on the prognosis of immunotherapy
Journal of Cancer Research and Clinical Oncology · 2024-09-07 · 150 (9)
DOI: 10.1007/s00432-024-05932-x ↗At a glance
Journal article in Journal of Cancer Research and Clinical Oncology, published online on 2024-09-07. Written by Guomin Gu and 6 co-authors. Institution: Department of Pulmonary Medicine, Affiliated Cancer Hospital of Xinjiang Medical University, No. 789 Suzhou East Street, Xincheng District, Urumqi, X…. Major MEDLINE topics: Carcinoma, Non-Small-Cell Lung, Proto-Oncogene Proteins p21(ras), Lung Neoplasms, Mutation. Cited 8 times so far (Crossref); 38 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Key Laboratory of Oncology of Xinjiang Uyghur Autonomous Region, Department of Science and Technology of Xinjiang Uygur Autonomous Region.
Abstract (original language)
Není k dispozici žádný abstrakt.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Pulmonary Medicine, Affiliated Cancer Hospital of Xinjiang Medical University, No. 789 Suzhou East Street, Xincheng District, Urumqi, Xinjiang, 830011, China.
- Education and Research Management Office, Affiliated Cancer Hospital of Xinjiang Medical University, No. 789 Suzhou East Street, Xincheng District, Urumqi, Xinjiang, 830011, China.
- Department of Breast and Thyroid Surgery, Affiliated Cancer Hospital of Xinjiang Medical University, No. 789 Suzhou East Street, Xincheng District, Urumqi, Xinjiang, 830011, China. sung853219@126.com.
- Xinjiang Cancer Center/Key Laboratory of Oncology of Xinjiang Uyghur Autonomous Region, Urumqi, Xinjiang, 830011, China. sung853219@126.com.
Funding
- Key Laboratory of Oncology of Xinjiang Uyghur Autonomous Region
- Department of Science and Technology of Xinjiang Uygur Autonomous Region
Cite
APA
Gu, G., Liu, C., Zhu, X., Yang, Y., Song, S., Zhao, Y., & Sun, G. (2024). Clinical characteristics of KRAS mutation subtypes in non-small cell lung cancer population in Xinjiang, China, and their impact on the prognosis of immunotherapy. Journal of Cancer Research and Clinical Oncology, 150(9). https://doi.org/10.1007/s00432-024-05932-x
Vancouver
Gu G, Liu C, Zhu X, Yang Y, Song S, Zhao Y, et al. Clinical characteristics of KRAS mutation subtypes in non-small cell lung cancer population in Xinjiang, China, and their impact on the prognosis of immunotherapy. Journal of Cancer Research and Clinical Oncology. 2024;150(9). doi:10.1007/s00432-024-05932-x
BibTeX
@article{Gu2024,
author = {Gu, Guomin and Liu, Chunling and Zhu, Xiaodan and Yang, Yan and Song, Shuming and Zhao, Yan and Sun, Gang},
title = {Clinical characteristics of KRAS mutation subtypes in non-small cell lung cancer population in Xinjiang, China, and their impact on the prognosis of immunotherapy},
journal = {Journal of Cancer Research and Clinical Oncology},
year = {2024},
volume = {150},
number = {9},
doi = {10.1007/s00432-024-05932-x}
}
EUVIMED